AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Effect of Oliceridine Patient-Controlled Intravenous Analgesia on Postoperative Chronic Pain After Video-Assisted Thoracoscopic Lung Resection

RecruitingPhase 4Ages 18 Years - 75 YearsAllTianjin Medical University General Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The primary objective is to evaluate the impact of oliceridine versus sufentanil for perioperative analgesia on the incidence of chronic postsurgical pain (CPSP) with functional impact in patients undergoing video-assisted thoracoscopic surgery.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age 18-75 years * ASA physical status I-III * BMI 18-35 kg/mยฒ * Scheduled for unilateral video-assisted thoracoscopic surgery (VATS) lung resection, including wedge resection, segmentectomy, lobectomy, or radical resection for lung cancerresection for lung cancer * Preoperative Numeric Rating Scale (NRS) pain score of 0 * Ability to understand the study objectives and procedures, with voluntary informed consent obtained * Expected postoperative recovery in the general ward setting Exclusion Criteria: * History of chronic pain or long-term analgesic use prior to surgery * Previous ipsilateral thoracic surgery * Prior neoadjuvant radiotherapy or chemotherapy * Severe cardiovascular or cerebrovascular disease, or hepatic/renal dysfunction (ALT/AST \> 3 ร— upper limit of normal; eGFR \< 60 mL/min/1.73 mยฒ) * Severe or unstable psychiatric disorders requiring psychoactive medication (e.g., schizophrenia, bipolar disorder), or cognitive impairment precluding reliable self-report * Other concurrent active malignancy or active infection * Known hypersensitivity to study medications (opioids, adjuvant analgesics, anesthetics, or antiemetics) * Pregnancy, lactation, or planned pregnancy during the study period * Participation in another interventional clinical trial within 3 months before enrolment * Any condition deemed unsuitable for study participation by the investigator
๐Ÿ’Š

What it tests

  • Oliceridine
  • Sufentanil
๐Ÿ“

Where

7 sites
The No. 2 Hospital of Baoding
Baoding, China
North China University of Science and Technology Affiliated Hospital
Tangshan, China
Tianjin Medical University General Hospital
Tianjin, China
Haibin People's Hospital of Tianjin Binhai New Area
Tianjin, China
The People's Hospital of Jizhou District, Tianjin
Tianjin, China
The Second Hospital of Tianjin Medical University
Tianjin, China
Tianjin Cancer Hospital Airport Hospital
Tianjin, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy